Expert Pulmonology for Lung Nodules and Lung Cancer in Shanghai
Not every lung nodule is cancer — and not every lung cancer patient needs the same treatment. The challenge lies in making the right distinction, quickly and accurately, so that patients who need treatment receive it without delay, and patients with benign disease are spared unnecessary intervention. At Shanghai Chest Hospital, Dr. Shen Jie brings the perspective of an experienced respiratory physician to the complex task of lung nodule evaluation and individualized lung cancer management.
Featured Specialist: Dr. Shen Jie (沈洁)
Dr. Shen Jie is a senior respiratory physician (Chief Physician / 主任医师) in the Department of Respiratory Medicine at Shanghai Chest Hospital (Shanghai Shi Xiongke Yiyuan), affiliated with Shanghai Jiao Tong University School of Medicine. Her clinical expertise spans:
- Differential diagnosis of pulmonary nodules and masses — distinguishing malignant from benign causes with precision
- Lung cancer chemotherapy — individualized regimen selection based on histological subtype, performance status, and comorbidities
- Targeted therapy for lung cancer — EGFR, ALK, and other driver mutation-directed treatments
- Comprehensive management of benign lung diseases that may mimic lung cancer on imaging
The Diagnostic Challenge: What Else Can Look Like Lung Cancer?
One of the most important skills in pulmonology is recognizing conditions that can mimic lung cancer on CT imaging. Dr. Shen's expertise in differential diagnosis protects patients from both under-diagnosis (missing a real cancer) and over-diagnosis (treating a benign condition as cancer). Common mimics include:
- Pulmonary tuberculosis (TB): Particularly common in Asia; can produce nodules, masses, and cavities that closely resemble lung cancer on CT
- Non-tuberculous mycobacterial (NTM) infection: Increasingly recognized; produces nodular and cavitary lesions
- Fungal infections: Aspergilloma, cryptococcosis, and histoplasmosis can all produce lung masses
- Organizing pneumonia: An inflammatory condition that produces consolidation and nodules, sometimes indistinguishable from cancer without biopsy
- Pulmonary carcinoid tumors: Low-grade neuroendocrine tumors that require different management from NSCLC
- Lymphoma: Can present as pulmonary nodules or mediastinal masses
- Metastases from other primary cancers: Require identification of the primary site before treatment
- Benign granulomas: Calcified or non-calcified; often require follow-up rather than intervention
Dr. Shen's respiratory medicine background gives her particular expertise in infectious and inflammatory lung conditions — ensuring that patients with benign disease are correctly identified and appropriately managed, while those with true malignancy are referred promptly for oncological treatment.
Individualized Lung Cancer Treatment
For patients confirmed to have lung cancer, Dr. Shen provides comprehensive individualized medical oncology management:
Chemotherapy
- Platinum-based doublet chemotherapy (cisplatin or carboplatin + pemetrexed, gemcitabine, paclitaxel, or docetaxel) for NSCLC
- Etoposide + platinum for small cell lung cancer (SCLC)
- Dose individualization based on renal function, performance status, age, and comorbidities
- Supportive care optimization — anti-emetics, growth factors, nutritional support to maintain treatment tolerance
- Maintenance chemotherapy (pemetrexed) for non-squamous NSCLC after platinum-based induction
Targeted Therapy
- EGFR TKIs (gefitinib, erlotinib, afatinib, osimertinib, aumolertinib) for EGFR-mutated NSCLC
- ALK inhibitors (crizotinib, alectinib, brigatinib) for ALK-rearranged NSCLC
- ROS1 inhibitors for ROS1-rearranged NSCLC
- Anti-angiogenic agents (bevacizumab, anlotinib) in combination with chemotherapy or as maintenance
- Resistance management — liquid biopsy and re-biopsy to identify resistance mechanisms and guide next-line therapy
The Internal Medicine Perspective: Complementing Surgical Care
Dr. Shen's respiratory medicine expertise complements the surgical expertise of thoracic surgeons at Shanghai Chest Hospital. For patients who are not surgical candidates — due to advanced stage, poor pulmonary function, or medical comorbidities — Dr. Shen provides the primary oncological management. For patients who have had surgery, she coordinates adjuvant systemic therapy and long-term surveillance.
This internal medicine perspective is also invaluable for:
- Managing treatment-related toxicities from chemotherapy or targeted therapy
- Evaluating pulmonary function before and after treatment
- Managing concurrent respiratory conditions (COPD, interstitial lung disease) that complicate lung cancer treatment
- Coordinating palliative and supportive care for patients with advanced disease
How CMCS Coordinates Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading respiratory and lung cancer specialists, including Dr. Shen Jie at Shanghai Chest Hospital, and manage every step of the process:
- Review of existing CT imaging, PET-CT, biopsy results, and molecular profiling reports
- Consultation scheduling with Dr. Shen's respiratory medicine team
- Coordination with thoracic surgery, interventional pulmonology, and radiation oncology as needed
- Medical interpretation during consultations and treatment planning discussions
- Logistics support: accommodation, visa assistance, and local transport
- Post-consultation follow-up and remote monitoring coordination
Get in Touch
If you have a lung nodule requiring expert evaluation, or have been diagnosed with lung cancer and need individualized medical oncology management in Shanghai, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0 commentaire